Navigating Therapeutic Advances in EGFR-Mutated NSCLC

ASCO Daily News by American Society of Clinical Oncology (ASCO)

Mar 19, 202619:24Science & Medicine

Dr. Monty Pal and Dr. Vamsi Velcheti discuss the evolving treatment landscape in EGFR-mutated non-small cell lung cancer, including landmark trials like FLAURA2, novel drug therapies, and the growing importance of ctDNA...

Related Episodes

Continue listening to more episodes from ASCO Daily News.

Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1

Jun 30, 2026 - 24:37

Dr. Megan Kruse and Dr. Hope Rugo discuss practice-changing data in metastatic breast cancer and critical...

GU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPART

Jun 25, 2026 - 30:28

Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss high-impact abstracts in the treatment of prostate...

Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers

Jun 24, 2026 - 29:43

Dr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in m...

GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More

Jun 23, 2026 - 22:46

Dr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other nov...

Hematologic Cancer Highlights From ASCO26: MajesTEC-9, frontMIND, and More

Jun 19, 2026 - 25:05

Dr. Marc Braunstein and Dr. Adam Kittai highlight top research on hematologic malignancies from the 2026...

Lung Cancer Highlights From ASCO26: HARMONi-6, LIBRETTO-436, and More

Jun 18, 2026 - 22:54

Dr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 20...

Day 5: Top Takeaways From ASCO26

Jun 2, 2026 - 09:35

Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia i...

Day 4: Top Takeaways From ASCO26

Jun 1, 2026 - 08:45

Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated...